Reduction in mother-to-child transmission of HIV in Thailand, 2001–2003: results from population-based surveillance in six provinces
Authors:
- Thananda NaiwatanakulTNThananda Naiwatanakul
- Niramon RattanasupornNRNiramon Rattanasuporn
- Orapan SangwanloyOSOrapan Sangwanloy
- Pornsinee AmornwichetPAPornsinee Amornwichet
- Achara TeeraratkulATAchara Teeraratkul
- Kumnuan UngchusakKUKumnuan Ungchusak
- Philip MockPMPhilip Mock
- William LevineWLWilliam Levine
- Michelle S McConnellMMMichelle S McConnell
- Rj SimondsRSRj Simonds
- Mary CulnaneMCMary Culnane
- 11 January 2007
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 21 (2) , 145-151
Abstract
In 2000, Thailand implemented a national program to prevent mother-to-child HIV transmission (PMTCT). To describe the effectiveness of the prevention of mother-to-child HIV transmission program in Thailand. A register of HIV-exposed children at birth was created with follow-up of infection status. The register included children born to HIV-infected women between 1 January 2001 and 31 December 2003 at 84 public health hospitals in six provinces of Thailand. The main outcome measure was HIV infection in children. A total of 2200 children born to HIV-infected mothers were registered. Of these mother-infant pairs, 2105 (95.7%) received some antiretroviral prophylaxis, including 1358 (61.7%) who received the complete short-course zidovudine regimen during pregnancy and labor for the mother and after birth for the infant, with or without other antiretrovirals. HIV infection outcome was determined for 1667 (75.8%) children, of whom 158 [9.5%, 95% confidence interval (CI), 8.1-11.0%] were infected. Transmission risk was 6.8% (95% CI 5.2-8.9%) among 761 mother-infant pairs that received the complete zidovudine regimen alone, and 3.9% (95% CI, 2.2-6.6%) among 361 mother-infant pairs that received the complete zidovudine regimen combined with other antiretrovirals, usually nevirapine. The overall transmission risk from this cohort, including all antiretroviral prophylaxis combinations, is estimated to be 10.2%. The Thai national PMTCT program is effective in reducing mother-to-child transmission risk from the historical risk of 18.9-24.2%. The addition of nevirapine to short-course zidovudine beginning in 2004 may further improve program effectiveness in Thailand.Keywords
This publication has 10 references indexed in Scilit:
- Evaluating Programs to Prevent Mother-to-Child HIV Transmission in Two Large Bangkok Hospitals, 1999-2001JAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in ThailandNew England Journal of Medicine, 2004
- Preventing Mother-to-Child HIV TransmissionJAMA, 2002
- National program for preventing mother–child HIV transmission in Thailand: successful implementation and lessons learnedAIDS, 2002
- Thai Red Cross zidovudine donation program to prevent vertical transmission of HIV: the effect of the modified ACTG 076 regimenAIDS, 2000
- A Trial of Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1New England Journal of Medicine, 2000
- Implementing short-course zidovudine to reduce mother???infant HIV transmission in a large pilot program in ThailandAIDS, 2000
- Prevention of Mother-to-Child HIV Transmission in Resource-Poor CountriesJAMA, 2000
- Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trialThe Lancet, 1999
- Maternal Virus Load and Perinatal Human Immunodeficiency Virus Type 1 Subtype E Transmission, ThailandThe Journal of Infectious Diseases, 1999